Showing results (471-480 of 2,106) with videos related to

Sort By:
Pageof 211
CNS Drugs|April 8, 2025
Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson's DiseaseHannah A Blair
CNS Drugs|February 27, 2026
Therapeutic Potential of PCSK9 Inhibitors in Regulating Neuroinflammation in Acute Ischemic StrokeLanlan Pu, Jiahui Liu, Shuying Kong, et al.
CNS Drugs|March 3, 2026
Multiple Adverse Outcomes Associated with Risperidone in People with Dementia: An Individual Participant Data Meta-AnalysisHieu T Le, Edward C Y Lau, Christine Y Lu, et al.
CNS Drugs|February 26, 2026
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysisTiffany J Pan, Hui Jue Wang, Almira Siddiqui, et al.
CNS Drugs|March 15, 2024
Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal PeriodKathrine Bang Madsen, Mette Bliddal, Charlotte Borg Skoglund, et al.
CNS Drugs|February 24, 2024
Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World DataSenta Frol, Janja Pretnar Oblak, Mišo Šabovič, et al.
CNS Drugs|July 25, 2023
Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-AnalysisQian Li, Xin Li, Chong Ye, et al.
CNS Drugs|July 28, 2023
The Utilization of Low Dose Naltrexone for Chronic PainSalomon Poliwoda, Bryant Noss, Gia Thinh D Truong, et al.
CNS Drugs|March 28, 2026
Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer's Disease: A Real‑World Retrospective Cohort Study with Treatment Effect Heterogeneity AnalysisChen Jiang, Josh Krivinko, Zeshui Yu, et al.
CNS Drugs|May 9, 2024
FcRn Inhibitor Therapies in Neurologic DiseasesNouf Alfaidi, Salama Karmastaji, Alexandria Matic, et al.
Pageof 211